Continuous treatment improves survival of newly diagnosed multiple myeloma patients achieving complete response: data from 5 phase III trials including young and elderly patients... by Cerrato, C, Gay, F, Petrucci, M.T, Pellegrino, M, Gaidano, G, Offidani, M, el Jarari, L, Gugielmelli, T, Salvini, M, Patriarca, F, Semenzato, G, Zweegman, S, Di Raimondo, F, Mina, R, Cascavilla, N, Yehuda, D.B, Gambella, M, Corradini, P, Lokhorst, H, Catalano, L, Di Bartolomeo, P, Hajek, R, Spencer, A, Boccadoro, M, Sonneveld, P, Palumbo, A

Get full text

First Analysis of HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Adriamycine, Dexamethasone (PAD) Vs VAD as Induction Treatment Prior to High Dose Melphalan (HD... by Sonneveld, P., van der Holt, B., Schmidt-Wolf, I.G.H., Bertsch, U., Jarari, L. el, Salwender, Hans-Jürgen, Zweegman, S., Vellenga, E., Schubert, J., Blau, I.W., Jie, GSK, Beverloo, B., Jauch, A., Hose, D., Schaafsma, R., Kersten, M.J., Delforge, M., de Weerdt, O., van der Griend, R., Wijermans, P.W., Martin, Hans, van der Velde, H., Lokhorst, Henk M., Goldschmidt, H.

Get full text

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/G... by Broyl, Annemiek, Dr, Corthals, Sophie L, MSc, Jongen, Joost LM, MD, van der Holt, Bronno, PhD, Kuiper, Rowan, BSc, de Knegt, Yvonne, BSc, van Duin, Mark, PhD, el Jarari, Laila, MSc, Bertsch, Uta, MD, Lokhorst, Henk M, Prof, Durie, Brian G, MD, Goldschmidt, Hartmut, Prof, Sonneveld, Pieter, Prof

Get full text